P

PLx Pharma Inc
F:1D5A

Watchlist Manager
PLx Pharma Inc
F:1D5A
Watchlist
Price: 0.0005 EUR Market Closed
Market Cap: 210k EUR

Operating Margin
PLx Pharma Inc

-1 417.8%
Current
-11 364%
Average
5.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1 417.8%
=
Operating Profit
-64.4m
/
Revenue
4.5m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
US
PLx Pharma Inc
F:1D5A
210k EUR
-1 418%
US
Eli Lilly and Co
NYSE:LLY
1T USD
44%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
US
Johnson & Johnson
NYSE:JNJ
491.8B USD
27%
CH
Roche Holding AG
SIX:ROG
271.4B CHF
34%
UK
AstraZeneca PLC
LSE:AZN
220.4B GBP
24%
US
Merck & Co Inc
NYSE:MRK
274.9B USD
38%
CH
Novartis AG
SIX:NOVN
218.8B CHF
33%
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
42%
IE
Endo International PLC
LSE:0Y5F
213.9B USD
11%
US
Pfizer Inc
NYSE:PFE
144.9B USD
29%
No Stocks Found

PLx Pharma Inc
Glance View

Market Cap
210k EUR
Industry
Pharmaceuticals

PLx Pharma, Inc. is a late-stage specialty pharmaceutical company, which engages in the development and commercialization of technology platform for approved drugs. The company is headquartered in Sparta, New Jersey and currently employs 16 full-time employees. The company went IPO on 2014-03-13. The firm has two commercialized products, VAZALORE 81 milligram (mg) and VAZALORE 325 mg, which are liquid-filled aspirin capsules for over the counter (OTC) distribution. The firm markets VAZALORE to the healthcare professional and the consumer through several sales and marketing channels. Its product pipeline also includes other oral NSAIDs using the PLxGuard drug delivery platform, including PL1200 Ibuprofen 200 mg and PL1100 Ibuprofen 400 mg, for pain and inflammation in Phase I clinical stage. PLxGuard drug delivery platform employs a pH-dependent release mechanism that relies on association of lipidic excipients with APIs for targeted release in the GI tract.

1D5A Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1 417.8%
=
Operating Profit
-64.4m
/
Revenue
4.5m
What is the Operating Margin of PLx Pharma Inc?

Based on PLx Pharma Inc's most recent financial statements, the company has Operating Margin of -1 417.8%.

Back to Top